Advertisement

Implantation: Pre-operative Evaluation to Discharge

  • Wolfram Grimm
  • Francis E. Marchlinski
Chapter
  • 61 Downloads
Part of the Developments in Cardiovascular Medicine book series (DICM, volume 188)

Abstract

THOROUGH preimplant evaluation of the patient’s physical condition and arrhythmias is crucial to successful ICD implantation and long-term clinical efficacy of the implanted device. The first approved devices in the United States used epi-cardial lead systems which have demonstrated long-term stability of the defibrillation threshold (DFT).1,2 The less invasive nonthora-cotomy lead system approach, however, appears to result in a significantly lower perioperative morbidity and mortality with an excellent short-term clinical efficacy.3, 4, 5 Since nonthoracotomy lead systems can be implanted in virtually all patients when biphasic shock waveforms are being used3 with similar low intraoperative DFTs as compared to what has been reported for conventional epi-cardial lead systems with monophasic shock waveforms, the nonthoracotomy approach has already become the primary method of ICD implantation.

Keywords

Implantable Cardioverter Defibrillator Lead System Defibrillation Threshold Biphasic Waveform Transvenous Lead 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Frame R, Brodman R, Furman S, et al. Long-term stability of defibrillation thresholds with intrapericardial defibrillator patches. PACE 1993;16(II):208–212.PubMedCrossRefGoogle Scholar
  2. 2.
    Wetherbee JN, Chapman PD, Troup PJ, et al. Long-term internal cardiac defibrillation threshold stability. PACE 1989;12:443–450.PubMedCrossRefGoogle Scholar
  3. 3.
    Block M, Hammel D, Böcker D, et al. A prospective randomized cross-over comparison of mono-and biphasic defibrillation using nonthoracotomy lead configurations in humans. J Cardiovasc Electrophysiol 1994;5:581–590.PubMedCrossRefGoogle Scholar
  4. 4.
    Saksena S, and the PCD Investigators. Defibrillation thresholds and perioperative mortality associated with endocardial and epicardial defibrillation lead systems. PACE 1993;16:202–207.PubMedCrossRefGoogle Scholar
  5. 5.
    Bardy GH, Hofer B, Johnson G, et al. Implantable transvenous cardioverter defibrillators. Circulation 1993;87:1152–1168.PubMedCrossRefGoogle Scholar
  6. 6.
    Marchlinski FE, Flores BF, Miller JM, et al. Relation of the intraoperative défibrillation threshold to successful postoperative defibrillation with an automatic implantable cardioverter defibrillator. Am J Cardiol 1988;62:393–398.PubMedCrossRefGoogle Scholar
  7. 7.
    Raitt MH, Johnson G, Dolack GL, et al. Clinical predictors of the defibrillation threshold with the unipolar implantable defibrillator system. J Am Coll Cardiol 1995;25:1576–1583.PubMedCrossRefGoogle Scholar
  8. 8.
    Grimm W, Flores BF, Marchlinski FE. Complications of implantable cardioverter defibrillator therapy: followup of 241 patients. PACE 1993;16:218–222.PubMedCrossRefGoogle Scholar
  9. 9.
    Grimm W, Flores BF, Marchlinski FE. Electrocardiographically documented unnecessary, spontaneous shocks in 241 patients with implantable cardioverter defibrillators. TACE 1992;15:1667–1672.Google Scholar
  10. 10.
    Dolack GL, Poole JE, Kudenchuk PJ, et al. Management of ventricular fibrillation with transvenous defibrillators without baseline electrophysiologic testing or antiarrhythmic drugs. J Cardiovasc Electrophysiol 1996;7:197–202.PubMedCrossRefGoogle Scholar
  11. 11.
    Kail JG, Kopp D, Lonchyna V, et al. Implantation of a subcutaneous lead array in combination with a transvenous defibrillation electrode via a single infraclavicular incision. PACE 1995;18:482–485.CrossRefGoogle Scholar
  12. 12.
    Schofield IJ, Rankin I, Bennett DH. Right sided pectoral implantation of an “active can” transvenous implantable cardioverter-defibrillator with single right ventricular lead. Br Heart J 1995;74:204.PubMedCrossRefGoogle Scholar
  13. 13.
    Epstein AE, Kay GN, Plumb VJ, et al. Elevated defibrillation threshold when right-sided venous access is used for nonthoracotomy implantable defibrillator lead implantation. The Endotak investigators. J Cardiovasc Electrophysiol 1995;6:979–986.PubMedCrossRefGoogle Scholar
  14. 14.
    Watkins L, Taylor E. The surgical aspects of automatic implantable cardioverter defibrillator implantation. PACE 1991;14:953–960.PubMedCrossRefGoogle Scholar
  15. 15.
    Watkins L, Mirowski M, Mower MM, et al. Implantation of the automatic defibrillator: the subxyphoid approach. Ann Thorac Surg 1982;34:515–520.PubMedCrossRefGoogle Scholar
  16. 16.
    Brodman R, Fisher JD, Furman S, et al. Implantation of the automatic cardioverter defibrillators via median sternotomy. PACE 1984;7:1363–1369.PubMedCrossRefGoogle Scholar
  17. 17.
    Lawrie G, Griffin JC, Wyndham CRC. Epicardial implantation of the automatic implantable defibrillator by left subcostal thoracotomy. PACE 1984;7:1370–1374.PubMedCrossRefGoogle Scholar
  18. 18.
    Cannom DS, Winkle RA. Implantation of the automatic cardioverter defibrillator (AICD). practical aspects. PACE 1986;9:793–809.PubMedCrossRefGoogle Scholar
  19. 19.
    Frumin H, Goodman GR, Pleatman M. ICD implantation via thoracoscopy without the need for sternotomy or thoracotomy. PACE 1993;16:257–260.PubMedCrossRefGoogle Scholar
  20. 20.
    Epstein AE, Kay GN, Plumb VJ, et al. Combined automatic implantable cardioverter-defibrillator and pacemaker systems: implantation techniques and followup. J Am Coll Cardiol 1989;13:121–131.PubMedCrossRefGoogle Scholar
  21. 21.
    Haffajee C, Casavant D, Desai P, et al. Combined third generation implantable cardioverter-defibrillator with dual-chamber pacemakers: preliminary observations. PACE 1996;19:136–142.PubMedCrossRefGoogle Scholar
  22. 22.
    Lehmann MH, Thomas A, Nabih M, et al. Sudden death in recipients of first-generation implantable cardioverter defibrillators: analysis of terminal events. J Interven Cardiol 1994;7:487–503.CrossRefGoogle Scholar
  23. 23.
    Lehmann MH, Saksena S. Implantable cardioverter defibrillators in cardiovascular practice: Report of the Policy Conference of the North American Society of Pacing and Electrophysiology. PACE 1991;14:969–979.PubMedCrossRefGoogle Scholar
  24. 24.
    Winkle RA, Mead RH, Ruder MA, et al. Effect of duration of ventricular fibrillation on defibrillation efficacy in humans. Circulation 1990;81:1477–1481.PubMedCrossRefGoogle Scholar
  25. 25.
    Marchlinski FE. Nonthoracotomy defibrillator lead systems — a welcomed addition but still a lot to learn. Circulation 1993;87:1410–1411.PubMedCrossRefGoogle Scholar
  26. 26.
    Lehmann MH, Steinman RT, Schuger CD, et al. Defibrillation threshold testing and other practices related to AICD implantation: do all roads lead to Rome? PACE 1989;12:1530–1537.PubMedCrossRefGoogle Scholar
  27. 27.
    Meesmann M. Factors associated with implantation related complications. PACE 1992;15:649–653.PubMedCrossRefGoogle Scholar
  28. 28.
    Frame R, Brodman R, Furman S, et al. Clinical evaluation of the safety of repetitive intraoperative defibrillation threshold testing. PACE 1992;15:870–877.PubMedCrossRefGoogle Scholar
  29. 29.
    Meyer J, Möllhoff Seifert T, et al. Cardiac output is not affected during intraoperative testing of the automatic implantable cardioverter defibrillator. J Cardiovasc Electrophysiol 1996;7:211–216.PubMedCrossRefGoogle Scholar
  30. 30.
    Pinski SL, Vanerio G, Castle LW, et al. Patients with a high defibrillation threshold: clinical characteristics, management and outcome. Am Heart J 1991;122:89–95.PubMedCrossRefGoogle Scholar
  31. 31.
    Epstein AE, Ellenbogen KA, Kirk KA, et al. Clinical characteristics and outcome of patients with high defibrillation thresholds — a multicenter study. Circulation 1992;86:1206–1216.PubMedCrossRefGoogle Scholar
  32. 32.
    Chen P-S, Shibata N, Dixon EG, et al. Comparison of defibrillation threshold and the upper limit of ventricular vulnerability. Circulation 1986;73:1022–1028.PubMedCrossRefGoogle Scholar
  33. 33.
    Kavanaugh KM, Harrison JH, Dixon EG, et al. Correlation of the probability of success curves for defibrillation and for the upper limit of vulnerability. PACE 1990;13:536. (abstract)Google Scholar
  34. 34.
    Chen P-S, Feld GK, Mower MM, et al. The effects of pacing rate and timing of defibrillation shock on the relationship between the defibrillation threshold and the upper limit of vulnerability in open chest dogs. J Am Coll Cardiol 1991;18:1555–1563.PubMedCrossRefGoogle Scholar
  35. 35.
    Fabritz CL, Kirchhof PF, Behrens S, et al. Myocardial vulnerability to T wave shocks: relation to shock strength, shock coupling interval, and dispersal of ventricular repolarization. J Cardiovasc Electrophysiol 1996:7;231–242.PubMedCrossRefGoogle Scholar
  36. 36.
    Chen P-S, Feld GK, Kriett JM, et al. Relation between upper limit of vulnerability and defibrillation threshold in humans. Circulation 1993;88:186–192.PubMedCrossRefGoogle Scholar
  37. 37.
    Hwang C, Swerdlow CD, Kass RM, et al. Upper limit of vulnerability reliably predicts the defibrillation threshold in humans. Circulation 1994;90:2308–2314.PubMedCrossRefGoogle Scholar
  38. 38.
    Swerdlow CD, Ahern T, Kass RM, et al. Upper limit of vulnerability is a good estimator of shock strength associated with 90% probability of successful defibrillation in humans with transvenous implantable cardioverter defibrillators. J Am Coll Cardiol 1996;27:1112–1118.PubMedCrossRefGoogle Scholar
  39. 39.
    Hii JTY, Gillis AM, Wyse DG, et al. Risks of developing supraventricular and ventricular tachyarrhythmias after implantation of a cardioverter-defibrillator, and timing the activation of arrhythmia termination therapies. An J Cardiol 1993;71:565–568.CrossRefGoogle Scholar
  40. 40.
    Kim SG, Fischer JD, Furman S, et al. Exacerbation of ventricular arrhythmias during the postoperative period after implantation of an automatic defibrillator. J Am Coll Cardiol 1991;18:1200–1206.PubMedCrossRefGoogle Scholar
  41. 41.
    Kelly PA, Cannom DS, Garan H, et al. The automatic implantable cardioverter-defiferillator: efficacy, complications and survival in patients with malignant ventricular arrhythmias. J Am Coll Cardiol 1988;11:1278–1286.PubMedCrossRefGoogle Scholar
  42. 42.
    Brunn J, Block M, Weber M, et al. Routinely performed tests of the defibrillation function of ICDs are not mandatory. NASPE 1996;19:605. (abstract)Google Scholar
  43. 43.
    Goldberger J, Inbar S, Burke J, et al. Utility of one month transvenous implantable defibrillator tests. PACE 1996;19:676. (abstract)Google Scholar
  44. 44.
    Gottlieb CD, Horowitz LN. Potential interactions between antiarrhythmic medication and the automatic implantable cardioverter defibrillator. PACE 1991;14:898–904.PubMedCrossRefGoogle Scholar
  45. 45.
    Har-Shai Y, Amikam S, Bolous M, et al. The management of soft tissue complications related to pacemaker implantations. J Cardiovasc Surg 1995;35:211–217.Google Scholar
  46. 46.
    Strickberger SA, Niebauer M, Man KC, et al. Comparison of implantation of nonthoracotomy defibrillators in the operating room versus the electrophysiology laboratory. Am J Cardiol 1995;75:255–257.PubMedCrossRefGoogle Scholar
  47. 47.
    Trappe HJ, Pfitzner P, Heintze J, et al. Cardioverter-defibrillator implantation in the catheterization laboratory: observations in 105 patients. Zeit fur Kardiol 1995;84:385–393.Google Scholar
  48. 48.
    Stix G, Anvari A, Grabenwöger, et al. Implantation of a unipolar cardioverter/ defibrillator system under local anaesthesia. Eur Heart J 1996;17:764–768.PubMedCrossRefGoogle Scholar
  49. 49.
    Tung RT, Bajaj AK. Safety of implantation of cardioverter-defibrillator without general anesthesia in an electrophysiology laboratory. Am J Cardiol 1995;75:908–912.PubMedCrossRefGoogle Scholar
  50. 50.
    McCowan RJ, Slayyeh Y, Cook F, et al. Transvenous implantation of cardioverter defibrillators in the electrophysiology laboratory at CAMC. W Virg Med J 1995;267–269.Google Scholar
  51. 51.
    Janosik D, Bjerreeaard P, Quattromani A, et al. Asymptomatic malfunction of chronic epicardial lead systems detected during cardioverter defibrillator replacement. PACE 1996;19:677. (abstract)Google Scholar

Copyright information

© Springer Science+Business Media New York 1996

Authors and Affiliations

  • Wolfram Grimm
  • Francis E. Marchlinski

There are no affiliations available

Personalised recommendations